Harvard Bioscience Inc. (NASDAQ:HBIO)’s share price traded down 3.7% on Friday . The company traded as low as $2.58 and last traded at $2.60, with a volume of 91,040 shares trading hands. The stock had previously closed at $2.70.

Separately, Zacks Investment Research lowered Harvard Bioscience from a “hold” rating to a “sell” rating in a research report on Tuesday, August 2nd.

The firm’s market capitalization is $89.21 million. The stock has a 50 day moving average of $2.82 and a 200 day moving average of $2.98.

Harvard Bioscience (NASDAQ:HBIO) last issued its quarterly earnings data on Thursday, July 28th. The company reported $0.03 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.03. The business earned $26.10 million during the quarter, compared to the consensus estimate of $26.60 million. On average, analysts predict that Harvard Bioscience Inc. will post $0.16 earnings per share for the current year.

Harvard Bioscience, Inc is a developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments. The Company’s products are used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories across the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.